E-resources
Peer reviewed
Open access
-
Napolitano, Valeria; Mróz, Piotr; Marciniak, Monika; Kalel, Vishal C.; Softley, Charlotte A.; Janna Olmos, Julian D.; Tippler, Bettina G.; Schorpp, Kenji; Rioton, Sarah; Fröhlich, Tony; Plettenburg, Oliver; Hadian, Kamyar; Erdmann, Ralf; Sattler, Michael; Popowicz, Grzegorz M.; Dawidowski, Maciej; Dubin, Grzegorz
European journal of medicinal chemistry, 12/2022, Volume: 243Journal Article
Trypanosomiases are neglected tropical diseases caused by Trypanosoma (sub)species. Available treatments are limited and have considerable adverse effects and questionable efficacy in the chronic stage of the disease, urgently calling for the identification of new targets and drug candidates. Recently, we have shown that impairment of glycosomal protein import by the inhibition of the PEX5-PEX14 protein-protein interaction (PPI) is lethal to Trypanosoma. Here, we report the development of a novel dibenzob,f1,4oxazepin-11(10H)-one scaffold for small molecule inhibitors of PEX5-PEX14 PPI. The initial hit was identified by a high throughput screening (HTS) of a library of compounds. A bioisosteric replacement approach allowed to replace the metabolically unstable sulphur atom from the initial dibenzob,f1,4thiazepin-11(10H)-one HTS hit with oxygen. A crystal structure of the hit compound bound to PEX14 surface facilitated the rational design of the compound series accessible by a straightforward chemistry for the initial structure-activity relationship (SAR) analysis. This guided the design of compounds with trypanocidal activity in cell-based assays providing a promising starting point for the development of new drug candidates to tackle trypanosomiases. Display omitted •Trypanosoma parasites cause severe disease and peroxisomal transport (PEX) is a valid drug target.•PEX5-PEX14 interaction inhibitors are delivered and SAR information is provided.•The developed small molecule PEX14 inhibitors kill Trypanosoma parasites in a cell-based assay.•Provided inhibitors offer a starting point for the development of pharmacologically relevant trypanocidal compounds.
Author
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.